A Pilot Study of the Feasibility of Setting up a Logbook for Allogeneic Haematopoietic Stem Cell Patients at the University Hospital of Amiens
NCT03149952 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2020-07-17
Summary
Hospitalization for allogeneic haematopoietic stem cell transplantation constitutes a particular time in the management of patients with malignant hemopathies both for the patient, for his entourage or for the nursing staff. For the patient, the strict protective isolation set up during this period is a source of isolation in the broad sense and is associated with an escape from external events and society. It also constitutes a physical barrier (mask, charlotte, surblouse and overshoes worn by caregivers or visitors) and even psychological in relations with relatives. Moreover, this period is also difficult because of the possible complications of conditioning (mucositis, transit disorders, fever ...) and allograft itself (graft versus host disease, no transplant, relapse disease…). The patient may be weakened and diminished, which can give a feeling of helplessness and uselessness to the family. Finally, this therapy can have serious physical and psychological consequences for the patient and his entourage (especially in the case of family allograft) who do not always have the possibility to express themselves verbally. Published studies in hematology report depressive, anxious and post-traumatic stress disorders in patients and relatives during allogeneic haematopoietic stem cell transplantation. It is therefore important to reduce these symptoms, particularly those related to the cut-off during hospitalization for allogeneic haematopoietic stem cells.
Over the last decade or so, the logbook has been used in some resuscitation services in intubated patients, with the main objective of filling the "memory gap" mentioned by the intubated patients when they woke up and limiting the trauma associated with this Cut in the world corresponding to the sedation period. For this purpose, the use of a logbook in Hematology, by analogy with what is used in the resuscitation services, could be a means of limiting the psychological complications related to the allograft.
Conditions
- Allogeneic Disease
- Hematopoietic Stem Cell
Interventions
- OTHER
-
Evaluation of the feasibility of the establishment of a logbook in patients hospitalized for allogeneic haematopoietic stem cells
Evaluation of the feasibility of the establishment of a logbook in patients hospitalized for allogeneic haematopoietic stem cells.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire, Amiens
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-13
- Primary Completion
- 2017-07-13
- Completion
- 2017-07-13
More Related Trials
-
Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03357172 ·Status: RECRUITING ·Phase: NA
-
Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study
NCT01095874 ·Status: COMPLETED
-
Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients
NCT02623309 ·Status: COMPLETED ·Phase: PHASE3
-
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
NCT04935684 ·Status: RECRUITING ·Phase: PHASE2
-
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
NCT01890486 ·Status: RECRUITING
-
Study of Drug Acceptance and Its Persistence Over Time in Patients Receiving a Haematopoietic Stem Cell Allograft
NCT05164835 ·Status: UNKNOWN ·Phase: NA
-
Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood
NCT00146055 ·Status: COMPLETED ·Phase: PHASE2
-
Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
NCT03244826 ·Status: COMPLETED ·Phase: NA
-
Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors
NCT06089850 ·Status: RECRUITING ·Phase: NA
-
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
NCT00106925 ·Status: RECRUITING
-
Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow
NCT02049424 ·Status: TERMINATED
-
The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family
NCT00795054 ·Status: COMPLETED
-
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
NCT00504803 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
NCT00005900 ·Status: UNKNOWN
-
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
NCT04528355 ·Status: RECRUITING
-
Diagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL
NCT04051372 ·Status: UNKNOWN
-
FMT In High-Risk Acute GVHD After ALLO HCT
NCT04139577 ·Status: COMPLETED ·Phase: PHASE1
-
Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation
NCT00461955 ·Status: COMPLETED ·Phase: PHASE2
-
Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03965429 ·Status: ACTIVE_NOT_RECRUITING
-
Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant
NCT01758484 ·Status: COMPLETED ·Phase: NA
-
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
NCT03000244 ·Status: RECRUITING
-
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
NCT03500731 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Unrelated Donor Transplant for Malignant and Non-Malignant Disorders
NCT01050439 ·Status: TERMINATED ·Phase: PHASE2
-
Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France
NCT04282421 ·Status: COMPLETED
-
Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide
NCT05768035 ·Status: RECRUITING ·Phase: PHASE1/PHASE2